CAMK2G and Alzheimer disease: Key findings include reduced autophosphorylation of CaMKII in the hippocampus and frontal cortex of patients with AD53, alterations in the subcellular localization of autophosphorylated CaMKII in the CA3 and DG of the AD-affected brain18, and inhibition of CaMKII activation by amyloid β54.